<h1 id="clostridium-difficile-infection-cdi-">Clostridium Difficile Infection (CDI)</h1>
<p><strong>TREATMENT</strong></p>
<table>
<colgroup>
<col width="50%" />
<col width="50%" />
</colgroup>
<thead>
<tr class="header">
<th><strong>Clinical category</strong></th>
<th><strong>Therapy</strong></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>1st episode, <br />
mild-mod severity</td>
<td><strong><span class="drug">Metronidazole</span></strong> 500 mg PO TID x 10-14 days</td>
</tr>
<tr class="even">
<td>1st episode, severe</td>
<td><strong><span class="drug">Vancomycin</span></strong> 125 mg PO QID x 10-14 days</td>
</tr>
<tr class="odd">
<td>1st episode, severe,complicated</td>
<td><strong><span class="drug">Vancomycin</span></strong> 500 mg QID PO/NG (PR if ileus) PLUS<br />

<p><strong><span class="drug">Metronidazole</span></strong> 500 mg IV q8h</p></td>
</tr>
<tr class="even">
<td>First recurrence</td>
<td>Same as for 1st episode (b/c minimal resistance<br />
rate)</td>
</tr>
<tr class="odd">
<td>Second and more recurrences</td>
<td><strong><span class="drug">Vancomycin</span></strong> PO in tapered or pulsed regimen.<br />

<p><strong>Avoid metronidazole</strong> overuse b/c of neurotoxicity.</p></td>
</tr>
</tbody>
</table>

<h2 id="background">Background</h2>
<p><strong>Definition of <em>Clostridium difficile</em> infection (CDI)</strong></p>
<ul>
<li>Presence of diarrhea (3 unformed stools in ≤24 hours)</li>
<li>Stool test positive for <em>C. difficile</em> or its toxins, or colonoscopic findings of pseudomembranous colitis</li>
</ul>
<p><strong>Epidemiology</strong></p>
<ul>
<li>Accounts for 20-30% of all antibiotic-associated diarrhea</li>
<li>Most common cause of infectious diarrhea in healthcare settings</li>
</ul>
<p><strong>Transmission</strong></p>
<ul>
<li>Fecal-oral route</li>
<li>Median time from exposure to C. difficile to diarrhea symptoms = 2-3 days</li>
</ul>
<p><strong>Risk factors to develop CDI</strong>
Age ≥ 65 years
Duration of hospitalization
Exposure to antibiotics (almost every Abx has been assoc with CDI – not just clindamycin)</p>
<ul>
<li>96% have received abx within 14 days before diarrhea onset </li>
</ul>
<p>Cancer chemotherapy
HIV
GI surgery or manipulation of GI tract (i.e. tube feeding)
<strong>Clinical presentation</strong></p>
<ul>
<li>Diarrhea may have mucous or occult blood</li>
</ul>
<p><strong>Recurrence rates</strong></p>
<ul>
<li>20% (typically within 4 weeks), despite metronidazole or vanco tx. (<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=18971494">Kelly et al., NEJM, 2008</a>)</li>
</ul>
<h2 id="complications">Complications</h2>
<ul>
<li>Bowel perforation</li>
<li>Dehydration</li>
<li>Electrolyte imbalance </li>
<li>Hypoalbuminemia</li>
<li>Hypotension</li>
<li>Renal failure</li>
<li>SIRS, sepsis, death</li>
<li>Toxic megacolon</li>
</ul>
<h2 id="references">References</h2>
<ul>
<li><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=20307191">Cohen SH, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by SHEA and IDSA. Infect Control Hosp Epidemiol. 2010; 31(5):431-55.</a></li>
<li><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=18971494">Kelly CP, LaMont JT.Clostridium difficile--more difficult than ever.N Engl J Med. 2008 Oct 30;359(18):1932-40. doi: 10.1056/NEJMra0707500.</a></li>
</ul>
